The implications of focal segmental glomerulosclerosis in children with IgA nephropathy
- PMID: 31773265
- DOI: 10.1007/s00467-019-04414-4
The implications of focal segmental glomerulosclerosis in children with IgA nephropathy
Abstract
Focal segmental glomerular sclerotic lesions in IgA nephropathy (IgAN), considered for years a chronic histologic feature related to proteinuria in remnant nephrons without any active role in the pathogenesis and progression of glomerular damage of IgAN, have been recently reconsidered. The Oxford classification of IgAN reported it as the "S" score and found it to be an independent risk factor for progression of IgAN. Its prognostic value was confirmed also in children. The identification of some histologic subvariants of the S lesion has produced interesting insights into different pathogenetic mechanisms of glomerular damage in IgAN. Tip lesion and podocyte hypertrophy are considered secondary to active podocytopathy and are correlated with higher levels of proteinuria and a faster decline in glomerular filtration rate. Moreover, endocapillary and mesangial hypercellularity might contribute in children with IgAN to formation and progression of S lesions. Considering the pathophysiology of these processes, children with some S features may benefit not only from nephroprotective measures but also from immunosuppression.
Keywords: Chronic kidney disease; Endocapillary hypercellularity; Glomerulosclerosis; Hypertension; IgA nephropathy; Mesangial hypercellularity; Proteinuria.
Similar articles
-
Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.Kidney Int. 2017 Jan;91(1):235-243. doi: 10.1016/j.kint.2016.09.029. Epub 2016 Dec 1. Kidney Int. 2017. PMID: 27914703
-
Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.Kidney Int. 2024 Jun;105(6):1279-1290. doi: 10.1016/j.kint.2024.03.011. Epub 2024 Mar 28. Kidney Int. 2024. PMID: 38554992
-
Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.Kidney Int. 2011 Mar;79(6):643-654. doi: 10.1038/ki.2010.460. Epub 2010 Dec 22. Kidney Int. 2011. PMID: 21178978
-
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22. Kidney Int. 2017. PMID: 28341274 Review.
-
Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.Nephrology (Carlton). 2016 Dec;21(12):995-1002. doi: 10.1111/nep.12850. Nephrology (Carlton). 2016. PMID: 27414046 Review.
Cited by
-
Dyslipidemia may be a risk factor for progression in children with IgA nephropathy.Pediatr Nephrol. 2022 Dec;37(12):3147-3156. doi: 10.1007/s00467-022-05480-x. Epub 2022 Mar 28. Pediatr Nephrol. 2022. PMID: 35347403
-
IgA nephropathy in children and in adults: two separate entities or the same disease?J Nephrol. 2020 Dec;33(6):1219-1229. doi: 10.1007/s40620-020-00725-0. Epub 2020 Apr 20. J Nephrol. 2020. PMID: 32314305 Review.
-
The successful use of rituximab in IgA nephropathy patients with podocytopathy: a case series.Clin Kidney J. 2024 Jun 27;17(8):sfae178. doi: 10.1093/ckj/sfae178. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39119523 Free PMC article.
-
Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO.J Nephrol. 2024 Apr;37(3):739-745. doi: 10.1007/s40620-023-01833-3. Epub 2024 Jan 18. J Nephrol. 2024. PMID: 38236471 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous